On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema
- 15 July 2018
- Vol. 73 (8), 1751-1753
- https://doi.org/10.1111/all.13324
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of OnsetInternational Archives of Allergy and Immunology, 2017
- Hereditary angioedema with a mutation in the plasminogen geneAllergy, 2017
- Families presenting with Carboxypeptidase N deficiency, 37 years after the single descriptionMolecular Immunology, 2017
- Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutationsJournal of Allergy and Clinical Immunology, 2016
- F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedemaAllergy, 2015
- Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitorHaemophilia, 2014
- Medical genomics: The intricate path from genetic variant identification to clinical interpretationApplied & Translational Genomics, 2014
- A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitorClinical Immunology, 2011
- Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitorBiochemical and Biophysical Research Communications, 2006